Skip to content
★ Sign in to follow
Total declarations
2
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (1 ops.)
€60k

Latest filing published 18 Mar 2021 for Neurogene Inc., €60k.

Filing timeline

BuySale
Robert Ho

Insider track record

Disclosed buys
0
Disclosed sells
1
Signal history

No signal scores available.

Robert Ho: trading record in brief

This profile gathers the share dealings of Robert Ho in Neurogene Inc. We count 2 filings; the first trade dates from 16 March 2021 and the latest from 17 March 2021.

Sales make up the whole of the open-market record (1 sale, €60k). Other entries cover 1 option exercise.

On 18 March 2021 came the latest disclosure, an open-market sale for €60k in Neurogene Inc. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Robert Ho

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations2 total
  • ▼
    Chief Financial OfficerExecutivesNeurogene Inc.
    71,532 USD39SEC
    6,497 shares@ US$11.01100.0% of flowCommon StockSEC:0001209191-21-021943:1
  • ◇
    Chief Financial OfficerExecutivesNeurogene Inc.
    0SEC
    25,000 shares0Common StockSEC:0001209191-21-021943:0

2 of 2 declarations